Search:
This item requires a subscription.
Naevoid basal cell carcinoma syndrome (Gorlin’s syndrome) DIP, Volume 11, Number 2.
Naevoid basal cell carcinoma syndrome (NBCCS), also called Gorlin’s syndrome and basal cell naevus syndrome, is a rare autosomal dominant disorder with an estimated prevalence of one in 55,600.1 Multiple names exist for the syndrome as none of them describes the condition perfectly. Professor Gorlin himself is opposed to the use of eponyms, yet he also feels that the syndrome’s current name of naevoid basal cell carcinoma syndrome is misleading, since not all patients manifest significant numbers of basal cell carcinomas (BCCs), particularly aggressive ones.2
To view this item, select one of the options below:
Purchase access
Sign in
email address
Password
Important
All the articles are in PDF format.
To view the articles you will need Adobe Acrobat Reader.
To download a copy, free of charge, please click here.